BioXcel Therapeutics saw the highest growth of 0.28% in patent filings and 1.32% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of BioXcel Therapeutics‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
BioXcel Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with six publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 29% grants. The European Patent Office(EPO), United States(US), World Intellectual Property Organization(WIPO), and Denmark(DK) patent Office are among the top ten patent offices where BioXcel Therapeutics is filings its patents. Among the top granted patent authorities, BioXcel Therapeutics has 29% of its grants in European Patent Office(EPO), 29% in United States(US) and 14% in Australia(AU).
AbbVie and Hisamitsu Pharmaceutical could be the strongest competitors for BioXcel Therapeutics
In terms of grant share, BioXcel Therapeutics stands first among its competitors followed by AbbVie and Hisamitsu Pharmaceutical.
Patents related to addiction and genomics lead BioXcel Therapeutics's portfolio
BioXcel Therapeutics has the highest number of patents in addiction followed by, genomics and rare diseases. For addiction, nearly 50% of patents were filed and 67% of patents were granted in Q2 2024.
Sedation related patents lead BioXcel Therapeutics portfolio followed by schizophrenia, and mania
BioXcel Therapeutics has highest number of patents in sedation followed by schizophrenia, mania, delirium, and dementia. For sedation, nearly 15% of patents were filed and 19% of patents were granted in Q2 2024.
For comprehensive analysis of BioXcel Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
